For example, a therapeutic enhancer in thalassemia, the half-E box/GATA1 binding site located in the BCL11A locus, is responsible for the erythrocyte expression of BCL11A, a key repressor of infant γ-globin expression 29. The gene discussed is BCL11A; the disease is thalassemia.